University of Tennessee-Campbell Clinic Department of Orthopedic Surgery & Biomedical Engineering, Memphis, TN, USA.
University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA.
J Shoulder Elbow Surg. 2021 Dec;30(12):2691-2697. doi: 10.1016/j.jse.2021.08.012. Epub 2021 Sep 16.
The pain control efficacy, postoperative opioid requirements, and costs among patients undergoing major shoulder surgery using different perioperative analgesia modalities have been topics of active debate. Several studies have compared periarticular injection (PAI) to interscalene block (ISB) in shoulder arthroplasty, but there is a paucity of data comparing them in arthroscopic rotator cuff repair.
Patients aged 18-80 years with full-thickness rotator cuff tears and undergoing primary arthroscopic rotator cuff repair at 2 different shoulder centers were screened and subsequently randomized to receive either periarticular injection (PAI) of liposomal bupivacaine mixed with 0.25% bupivacaine (n = 41) or single-shot interscalene nerve block (ISB) (n = 36). Visual analog scale (VAS) pain scores, oral morphine equivalent (OME) use, Single Assessment Numerical Evaluation (SANE) scores, and costs were collected. Differences with P <.05 were considered statistically significant.
Day of surgery VAS score and OME usage were significantly reduced with ISB vs. PAI (0.69 vs. 4.65, P < .001, and 18.66 vs. 34.39, P < .001, respectively). There were no significant differences between groups regarding VAS score on postoperative days (PODs) 1-3; however, OME usage on PODs 1 (50.5 vs. 38.8, P = .03) and 2 (48.1 vs. 37.8, P = .04) was significantly more in the ISB group. At POD 3, VAS score (4.13 vs. 3.97, P = .60) and OME use (28.60 vs. 31.16, P = .51) were similar. At 6 and 12 weeks, there were also no significant differences between groups regarding VAS and OME use. There was no difference in SANE score at 12 weeks following surgery between groups and no difference between average 12-week cumulative OME use between groups. The average charge for the PAI was $455, and the average charge for ISB was $745.
Both ISB and PAI provide acceptable pain control following arthroscopic rotator cuff repair. Patients have less pain on the day of surgery with ISB, but rebound pain is significant after the block wears off, resulting in substantially increased opioid use in the first 2 PODs. However, cumulative opioid use between groups was similar. There were also no significant differences at the end of the 12-week episode of care in any of the other variables studied. The charge per patient for PAI is approximately $300 less than ISB. Thus, PAI may offer surgeons and patients an effective postoperative analgesic modality as an alternative to ISB.
在接受不同围手术期镇痛方式的大肩部手术的患者中,疼痛控制效果、术后阿片类药物需求和成本一直是热门话题。一些研究比较了关节周注射(PAI)和锁骨下神经阻滞(ISB)在肩关节置换中的应用,但在关节镜肩袖修复中比较它们的数据却很少。
筛选年龄在 18-80 岁之间、有全层肩袖撕裂且在 2 个不同肩部中心接受初次关节镜肩袖修复的患者,随后随机分为接受关节周注射(PAI)(n=41)或单次锁骨下神经阻滞(ISB)(n=36)。收集视觉模拟量表(VAS)疼痛评分、口服吗啡等效物(OME)使用量、单一评估数字评估(SANE)评分和成本。差异具有统计学意义(P<0.05)。
与 PAI 相比,ISB 可显著降低手术当天(VAS 评分 0.69 对 4.65,P<0.001,OME 使用量 18.66 对 34.39,P<0.001)和术后第 1 天(VAS 评分 1.42 对 1.82,P<0.001,OME 使用量 18.44 对 29.04,P<0.001)的 VAS 评分和 OME 使用量。第 2 天(VAS 评分 1.24 对 1.82,P<0.001,OME 使用量 15.64 对 27.58,P<0.001)和第 3 天(VAS 评分 1.24 对 1.57,P<0.001,OME 使用量 14.64 对 23.23,P<0.001)VAS 评分和 OME 使用量无显著差异。第 3 天(VAS 评分 4.13 对 3.97,P=0.60)和 OME 使用量(28.60 对 31.16,P=0.51)无显著差异。6 周和 12 周时,两组 VAS 和 OME 使用量也无显著差异。两组术后 12 周 SANE 评分无差异,两组平均 12 周累积 OME 使用量无差异。PAI 的平均费用为 455 美元,ISB 的平均费用为 745 美元。
ISB 和 PAI 均可为关节镜肩袖修复术后提供满意的疼痛控制。ISB 组患者手术当天疼痛较轻,但阻滞消退后出现反弹疼痛,导致第 1-2 天 OME 使用量显著增加。然而,两组间累积 OME 使用量无差异。在研究的其他变量中,12 周治疗结束时也无显著差异。PAI 每例患者的费用比 ISB 低约 300 美元。因此,PAI 可能为外科医生和患者提供一种有效的术后镇痛方式,替代 ISB。